Targeted cancer therapies: Their use, effectiveness and cost effectiveness in real world clinical practice

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Cancer treatments come at a high price tag and are also released to the market earlier than ever before. The high costs can be a barrier to public funding and patient access and their early release means their risks and benefits are not fully understood, especially in the long-term. This project aims to examine the newer biological therapies - their use, costs and benefits in real-world clinical practice.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2014

Funding Scheme: NHMRC Postgraduate Scholarships

Funding Amount: $121,682.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Therapies And Therapeutic Technology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Cancer | Cost of Cancer Treatment | Health Care Utilisation | Health Outcomes | Targeted Therapies